House Calls and Decision Support: Improving Access to Live Donor Transplantation
Primary Purpose
Chronic Kidney Disease, End-Stage Renal Disease
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
House Calls
Web-Based Patient-Centered Decision Support Intervention
Sponsored by
About this trial
This is an interventional health services research trial for Chronic Kidney Disease focused on measuring Live Donor Kidney Transplantation, LDKT, African American, Disparity, Education, Patient Support
Eligibility Criteria
Inclusion Criteria:
- non-White race/Hispanic ethnicity/low-income (250% below federal poverty guidelines)
- CKD/ESRD
- meets eligibility criteria for kidney transplant waiting list
- 21 years old or older
- self-reports being in LDKT Readiness Stage I, II, or III
- Resides within 3 hours driving time from transplant center
Exclusion Criteria:
- Awaiting combined kidney-liver transplant
- Awaiting simultaneous pancreas-kidney transplant
- Know or suspected cognitive impairment
- Prior participation in House Calls intervention study
Sites / Locations
- Beth Israel Deaconess Medical Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
No Intervention
Arm Label
House Calls only
House Calls + Web-Based Decision Support
Control
Arm Description
60-minute educational intervention in patient's home which will be delivered by a health educator.
Home based intervention plus web-based patient-centered decision support program that will be offered to participants following the home based intervention.
100 patients on the Organ Transplant Tracking Record who are not receiving the study intervention
Outcomes
Primary Outcome Measures
The primary outcome for this study is the proportion of enrolled patients with live donor kidney transplants
Secondary Outcome Measures
Higher proportion of enrolled patients with live donor inquires and evaluations; higher proportion of patients will be in LDKT Readiness stages 4/5 by the 12-week assessment.
Full Information
NCT ID
NCT01786525
First Posted
February 6, 2013
Last Updated
July 13, 2020
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
1. Study Identification
Unique Protocol Identification Number
NCT01786525
Brief Title
House Calls and Decision Support: Improving Access to Live Donor Transplantation
Official Title
House Calls and Web-based Decision Support: Improving Access to Live Donor Kidney Transplantation
Study Type
Interventional
2. Study Status
Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
June 2013 (undefined)
Primary Completion Date
May 31, 2019 (Actual)
Study Completion Date
May 31, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Beth Israel Deaconess Medical Center
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The main purpose of this research program is to reduce the burden of end-stage organ disease on individuals, families, healthcare systems, and society by increasing the availability of donor organs for transplantation. Consistent with this aim, the project further examines strategies to increase access to and reduce disparities - racial, economic, gender - in live donor kidney transplantation (LDKT). Specifically, we expand the research and intensity of an innovative House Calls intervention developed by the principal investigator by including other minorities and socioeconomically disadvantaged patients and by adding a novel Patient-Centered Decision Support component. The main study hypothesis is that participants receiving the novel intervention (House Calls + Patient-Centered Decision Support) will have a higher proportion of LDKT's by the 2-year study endpoint.
Detailed Description
For most adults in late Chronic Kidney Disease (CKD Stage 4 or 5), kidney transplantation yields superior outcomes compared to long-term dialysis. Unfortunately, the demand for kidney transplantation far exceeds the supply of deceased donor organs. For those patients with healthy and willing living kidney donors, live donor kidney transplantation (LDKT) produces superior graft and patient survival rates, lower acute rejection rates, more rapid improvements in functional status, and lower healthcare costs. However, there are profound racial and income disparities in access to LDKT. Minorities, especially Blacks and Hispanics, are substantially less likely to receive LDKT compared to Whites. Also, the overall decline in LDKTs in the United States in recent years has been more pronounced for Blacks and patients with less household income. These lower LDKT rates contribute to longer waiting times for transplantation, more dialysis exposure, higher likelihood of death before transplantation, declining functional capacity, less optimal graft outcomes after transplantation, and higher healthcare costs. Therefore, interventions that expand access to LDKT, especially those targeting minority and low-income populations, are needed given the current and projected shortage of deceased donor organs.
There are several hypothesized barriers to LDKT for minorities and low-income patients, including perceived discrimination, health care mistrust, social network differences, higher rates of conditions that preclude living kidney donation, higher indirect costs of living donation, less knowledge and more concerns about LDKT, and failure to provide culturally competent education to patients and their support systems. In the last decade, the PI has developed and evaluated an innovative House Calls intervention designed to remove LDKT barriers.28-30 Health educators deliver a comprehensive and interactive program on kidney transplantation and living donation in the patient's home with members of their social network present. Relative to standard clinic-based educational programs, the House Calls intervention is superior at improving LDKT knowledge, reducing LDKT concerns, increasing LDKT willingness, and increasing rates of LDKT, particularly in minority and low-income patients (see Preliminary Studies section). However, the effectiveness of the House Calls intervention may be limited by the absence of decision-making aids, exposure to appropriate peer models, and assistance in developing an LDKT action plan beyond the House Calls intervention. This limitation and feedback from study participants have informed our strategy to enhance the House Calls intervention by incorporating a Patient-Centered Decision Support component. Additionally, there is a pressing need to identify factors that are most critical to the success of the House Calls intervention and to determine whether it can reduce the gender disparity in living kidney donation.8 Therefore, in the proposed study, we plan to pursue two primary aims and one exploratory aim:
Primary Aims
Evaluate the differential benefit of adding a patient-centered decision support component to the House Calls intervention. In a randomized controlled trial, we will compare House Calls (HC) alone to House Calls + Decision Support (HC+DS) in a sample of minorities and low-income patients. It is hypothesized that, compared to HC alone, the HC+DS group will have a higher proportion of patients with LDKT by the 2-yr study endpoint (primary outcome) and higher proportions of patients with ≥1 live donor inquiry, ≥1 live donor evaluation, and in LDKT Readiness Stages 4/5 by the 12-wk assessment (secondary outcomes).
Identify mediators of the relationship between the interventions and the occurrence of LDKT. We will investigate a set of mediators through which House Calls may increase the occurrence of LDKT, including increased LDKT knowledge, change in LDKT readiness, reduced LDKT concerns, reduced health care mistrust, the amount of time discussing LDKT with others and the quality of those interactions, and improvement in self-efficacy discussing LDKT with others.
Exploratory Aim
Examine whether the House Calls intervention reduces the gender disparity in rates of living kidney donation. Women comprise 60% of all living kidney donors in the past decade. We have shown that the House Calls intervention directly educates significantly more potential living donors, including men, compared to standard clinic-based educational approaches. We hypothesize that a higher proportion of patients receiving the House Calls intervention (either HC alone or HC+DS) will have at least one potential male donor evaluated and be more likely to receive a LDKT from a male living donor, relative to a non-intervention control group, controlling for patient race/ethnicity, gender, age, and household income.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Disease, End-Stage Renal Disease
Keywords
Live Donor Kidney Transplantation, LDKT, African American, Disparity, Education, Patient Support
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
109 (Actual)
8. Arms, Groups, and Interventions
Arm Title
House Calls only
Arm Type
Experimental
Arm Description
60-minute educational intervention in patient's home which will be delivered by a health educator.
Arm Title
House Calls + Web-Based Decision Support
Arm Type
Active Comparator
Arm Description
Home based intervention plus web-based patient-centered decision support program that will be offered to participants following the home based intervention.
Arm Title
Control
Arm Type
No Intervention
Arm Description
100 patients on the Organ Transplant Tracking Record who are not receiving the study intervention
Intervention Type
Behavioral
Intervention Name(s)
House Calls
Intervention Description
60-minute home based educational intervention which will be administered by a health educator
Intervention Type
Behavioral
Intervention Name(s)
Web-Based Patient-Centered Decision Support Intervention
Intervention Description
Patients will be provided with access to the study website which will allow them to learn and receive LDKT support in a way the best meets their personal values and preferences
Primary Outcome Measure Information:
Title
The primary outcome for this study is the proportion of enrolled patients with live donor kidney transplants
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Higher proportion of enrolled patients with live donor inquires and evaluations; higher proportion of patients will be in LDKT Readiness stages 4/5 by the 12-week assessment.
Time Frame
2 years
Other Pre-specified Outcome Measures:
Title
Improvement in LDKT knowledge and LKDT readiness, reduced LDKT concerns and health care mistrust, greater amount of time spent discussing LDKT and higher quality interactions, and improvement in self-efficacy discussing LDKT.
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
non-White race/Hispanic ethnicity/low-income (250% below federal poverty guidelines)
CKD/ESRD
meets eligibility criteria for kidney transplant waiting list
21 years old or older
self-reports being in LDKT Readiness Stage I, II, or III
Resides within 3 hours driving time from transplant center
Exclusion Criteria:
Awaiting combined kidney-liver transplant
Awaiting simultaneous pancreas-kidney transplant
Know or suspected cognitive impairment
Prior participation in House Calls intervention study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James R Rodrigue, PhD
Organizational Affiliation
Beth Israel Deaconess Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Didier Mandelbrot, MD
Organizational Affiliation
Beth Israel Deaconess Medical Center
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Martha Pavlakis, MS
Organizational Affiliation
Beth Israel Deaconess Medical Center
Official's Role
Study Chair
Facility Information:
Facility Name
Beth Israel Deaconess Medical Center
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02215
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
House Calls and Decision Support: Improving Access to Live Donor Transplantation
We'll reach out to this number within 24 hrs